Evidence & Performance Blog

Dear Readers and Contributors

As the end of the year is coming closer, we would like to write a few personal words.
Thanks to all of you, we were able to set up a great group, and we were able to launch our blog in June 08!
Your experience and advices helped us to grow and to continuously provide top notch information and feedback from the field.
We want to sincerely thank you - your contribution is essential to us!

We are already working on some innovation for our group so that the good communication keeps ongoing, and the group becomes even more interactive !
Any ideas and request for participation are welcome, don’t hesitate to contact us !

We wish you all the best for a prosperous, heathly and successful 2009 !
Happy New Year !

Your dedicated team

As part of our ever lasting goal to provide you with the most accurate information, we are pleased to share with you some words we exchanged with Vincent Wautelet, CTO of a young yet professionnal EDC Company in Belgium.

Read more

We had the pleasure to meet Doctor Pierre Le Sourd, former President of Bristol Myers Squibb France and most recently President of the Leem (The French Pharmaceutical Companies Association).

Mr Le Sourd brings us 30 years of pharmaceutical experience to help us understand current challenges and perspectives in this industry.

Read more

Lorena Levi, Trainer at Fundacion Cecilia Grierson in Argentina, is sharing with us her experience in operational and performance management in South / Latin America.

Lorena and myself talked about this in the past week, and I am now sharing her thoughts with you. Read more

Christophe De Vleeschouwer, Manager Medical Operations for Cordis Medical (a Johnson & Johnson company) in Belgium, is exposing his thoughts and needs about measuring performance for large cohort clinical registry. Christophe has met us last week, and Alex took his confessions. Read more

In your opinion, and based on your experience, which of the following root causes is curbing good clinical trial performance:

- Lack of methodology to assess metrics of performance, discontinuing the enhancement of informed decision
- Disparate and dispersed critical data, making difficult to have an integrated report “dash board” at a glance
- Isolated teams, creating painful communication loops and useless delays
- Other, please explain..

Leave us a comment with your answer !
We will write an article about the root causes of bad performance very soon, and it would be very useful to have all your thoughts on it !

Thanks

You just joined our LinkedIn group? This message is for you.

First of all, the team behind this blog wants to welcome you to Clinical Trial Performance Spot, the spot where you will be finding all kind of information about Clinical Trial Performance.

In fact we are going beyond just giving information! We want to share our interest about the need of performance in pharmaceutical companies. All our members should be able to advice each other how to reduce delay, time & cost while improving quality and efficiency.

Let me give you a small introduction on the way we thought the blog.
We have several categories on which we are simultaneously working:

• The industry news: here you will be able to find the latest and most interesting news from the global clinical market. Your comments are welcome.
• The technology: here we explain several concepts: what is called clinical trial performance, what is the current status in the market, how will it be measured…
• The methodoloy: here we want to share information about the current needs: what can be done to change the way the pharma companies operate, how can one measure its performance, or its service provider’s performance? The most important is that you share information with us as well.

The spot wants to become a place where we all interact and share information, sometimes agreeing, sometimes not. By pointing fingers on the problems you have to face to daily, we believe and trust in our capacity of resolving them. Someone had to face the same situations, and probably some solutions are on their way.
Tell us your truth – we help finding solutions and won’t forget it…

Stay ahead the curve with the Clinical Trial Performance Spot !

Your highly dedicated team !

All new medical products (drugs and medical devices) must follow harsh process of clinical development.

Starting from the earliest stage to very last step in the process of the clinical trial, there is place for potential delays and unexpected costs. Read more